Tenet Healthcare (NYSE:THC) Shares Gap Down – Time to Sell?

Tenet Healthcare Corporation (NYSE:THC) gapped down before the market opened on Friday . The stock had previously closed at $188.33, but opened at $179.01. Tenet Healthcare shares last traded at $177.7120, with a volume of 519,130 shares.

Analysts Set New Price Targets

A number of research firms recently commented on THC. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Tenet Healthcare in a report on Friday, March 27th. Wall Street Zen downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Guggenheim raised their price target on Tenet Healthcare from $271.00 to $283.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. Leerink Partners upped their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. Finally, Jefferies Financial Group upped their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Trading Down 4.0%

The stock’s 50 day simple moving average is $211.42 and its 200 day simple moving average is $204.65. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The firm has a market cap of $15.83 billion, a PE ratio of 11.67, a PEG ratio of 1.42 and a beta of 1.49.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the previous year, the firm posted $3.44 EPS. The firm’s revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts forecast that Tenet Healthcare Corporation will post 17.31 earnings per share for the current fiscal year.

Insider Activity

In related news, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at $6,983,853.13. The trade was a 18.16% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 46,517 shares of company stock worth $10,943,111. 0.81% of the stock is currently owned by insiders.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently added to or reduced their stakes in THC. Wedmont Private Capital grew its stake in shares of Tenet Healthcare by 2.5% during the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after buying an additional 50 shares during the last quarter. Baron Wealth Management LLC lifted its stake in shares of Tenet Healthcare by 4.8% in the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock valued at $227,000 after acquiring an additional 52 shares during the last quarter. Sagespring Wealth Partners LLC boosted its holdings in Tenet Healthcare by 3.6% during the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after acquiring an additional 55 shares during the period. Quadrant Capital Group LLC grew its position in Tenet Healthcare by 0.7% during the 4th quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after acquiring an additional 58 shares during the last quarter. Finally, Syon Capital LLC increased its stake in Tenet Healthcare by 5.3% in the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock worth $249,000 after purchasing an additional 63 shares during the period. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.